1. /
  2. Our work /
  3. Projects /
  4. NATNAT: Newly Adapted Tools and Network Against Mosquito Borne Disease Transmission
Natnat

NATNAT: Newly Adapted Tools and Network Against Mosquito Borne Disease Transmission

Past project

Papua New Guinea (PNG) accounts for the vast majority of malaria cases in the South Pacific Region. Malaria control in PNG consists of nationwide distribution of long-lasting insecticidal nets (LLINs) and case management with rapid diagnostic testing of febrile illness and treatment with artemether-lumfantrine.

Objective

Malaria transmission has been on the rise in PNG and the Solomon Islands in recent years and there is increasing recognition that LLINs alone will not lead to malaria elimination. 

However, at present there is no national vector control strategy or activities to control vector populations. PNG, and the region as a whole, currently has limited capacity to test the efficacy of novel Vector Control Tools (VCTs) against local vector species and in local transmission ecologies.

Specifically, NATNAT aims to:

  • strengthen laboratory and field capacity to test new VCTs
  • conduct rigorous field evaluations of new VCTs
  • investigate the community and health system acceptability of new VCTs
  • support a NMCP-led formal network for evaluating and establishing recommendations for vector control tools and interventions in PNG

NATNAT also aims to significantly improve the ability of PNG to assess and adopt novel VCTs relevant for the region.

This will allow for a more rapid pathway for the implementation of VCTs identified as being efficacious to the country.

Approach

Effective vector control to reduce malaria and other vector-borne infectious diseases in the South-Pacific is compromised by several fundamental vector-biological factors, mainly early and outdoor mosquito biting, plasticity in host selection (lack of anthropogenicity) and preference for a wide variety of habitats.

Lack of basic infrastructure and accessibility add to the challenges of implementing efficient vector control in PNG and several other South Pacific countries. Additional VCTs that efficiently reduce human vector contact under these conditions are urgently needed.

To address this problem, NATNAT will support the Papua New Guinea Institute of Medical Research (PNGIMR) and PNG NDoH to adopt a ‘framework for rapid assessment and adoption of new vector control tools’ (VCTs) for PNG and the South Pacific Region.

Timeline

2020–2023.

Burnet Logo Trademark Presentation (1)
1/3
210331 Png Natnat River 1 510X288
210331 Png Natnat Team 510X288
Image: The PNGIMR entomology team in Madang, PNG. Supplied by Petrina Johnson, JCU.
210331 Natnat Building
1/3

Tap an image to expand it in focused view

Funding partners

Funding partners

Supported by the Australian Government through the Department of Foreign Affairs and Trade’s Indo-Pacific Centre for Health Security, and the Innovative Vector Control Consortium (IVCC.

Partner logo

Collaborators

  • Dr Moses Laman, PNG Institute of Medical Research (PNGIMR)
  • Mr Leo Makita, Dr Melinda Susupu, PNG National Department of Health (NDoH)
  • Dr Stephan Karl, James Cook University (JCU); PNGIMR
  • Mr Tim Freeman, Rotarians Against Malaria (RAM)

Project contacts

Professor Leanne Robinson

Professor Leanne Robinson

Program Director, Health Security and Pandemic Preparedness; Senior Principal Research Fellow, Group Leader, Vector-Borne Diseases and Tropical Public Health
View profile

Project team

Marina Bishop

Marina Bishop

Senior Project Officer
View profile
Paul Daly

Paul Daly

Project Manager
View profile
Annie Dori

Annie Dori

Senior Partnership Manager
View profile
Rachael Farquhar

Rachael Farquhar

International Research Project Officer, Project Manager
View profile
Alexa Murray

Alexa Murray

Senior Research Officer & Project Manager
View profile
Professor Leanne Robinson

Professor Leanne Robinson

Program Director, Health Security and Pandemic Preparedness; Senior Principal Research Fellow, Group Leader, Vector-Borne Diseases and Tropical Public Health
View profile
On this page